Moreover, when ANXA1 was administered to mice before and after cerebral ischemia-reperfusion injury, the blood flow was significantly improved, indicating ANXA1-mediated an inhibitory effect on thrombosis as well as displayed its protective effects against recurrent post-stroke thrombotic events [10]. The gene discussed is ANXA1; the disease is stroke disorder.